Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Solulink Completes Equity Financing for HybriLink™ Antibody-Labeling Technology

Published: Friday, July 19, 2013
Last Updated: Friday, July 19, 2013
Bookmark and Share
New funding advances mission to provide flow cytometry users with a solution to the ‘missing color’ problem.

Solulink, Inc. announced the completion of a new round of equity financing. The funds will enable Solulink to accelerate the commercialization of its HybriLink ‘any antibody in any color’ labeling technology. The HybriLink technology satisfies flow cytometrists’ unmet needs and enables antibody suppliers to address market demand for greater flow cytometry multiplexing ease and convenience.

The HybriLink technology solves the ‘missing color’ problem: the inability to find the needed antibody labeled with the right fluorophore (color). Often, the desired combination is not commercially available. By providing a simple way to mix and match any fluorophore with any antibody on demand, just-in-time at the point-of-use, HybriLink dramatically streamlines the development and expansion of multicolor flow panels for flow cytometry research labs. Solulink believes that HybriLink’s ability to offer all antibodies in all fluorophores – including the next generation of emerging fluorophores – resolves a fundamental challenge in flow cytometry and will expand the overall flow cytometry reagents market size.

“With the HybriLink technology, antibodies are labeled with a tag and the fluorophores labeled with a complimentary tag. These two components are then combined to form the labeled antibody, ready to use with nearly 100% efficiency. Labeled-antibody providers can now supply tagged antibodies and complimentary tagged fluorophores, which allow the user to create an unlimited number of labeled antibodies,” said Solulink’s CEO, David McCarty.

“Solulink’s HybriLink technology simultaneously fulfills two increasingly critical needs in flow cytometry: HybriLink offers flow cytometrists an easy way to create, or optimize, multi-color flow panels on demand by labeling any antibody with any color, without chemistry or chromatography. In addition, HybriLink offers strategic partners a radically simplified way to introduce new fluorophores into their library of labeled antibodies, while expanding their market potential.”

The company is currently providing early access to HybriLink products to select customers. Attractive licensing terms are available for licensees and commercial partners in the flow cytometry and antibody reagents markets.

“Flow cytometry instruments and fluorophores have advanced rapidly; however, antibody-labeling technology has stagnated and the few advances have not met user or market expectations,” added Mark Horne, CEO, Plymouth Ventures. “Based on our diligence results, we are confident that the HybriLink technology represents a major advancement for flow cytometry and will be embraced by the research community.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Former Life Technologies and BD Biosciences Executive John L. “Kip” Miller Joins Solulink’s Board of Directors
Mr. Miller brings a successful track record of life science leadership and in-depth knowledge of the life science and flow cytometry markets to Solulink’s Board.
Wednesday, September 04, 2013
Scientific News
Charting Kidney Cancer Metabolism
Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Honey’s Potential to Save Lives
The healing powers of honey have been known for thousands of years.
3-D Printed Lifelike Liver Tissue for Drug Screening
A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling.
Cytoskeleton Crew
Findings confirm sugar's role in helping cancers survive by changing cellular architecture.
Biomarker for Recurring HPV-Linked Oropharyngeal Cancers
A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!